Literature DB >> 15024472

[Graves disease. An important differential diagnostic consideration for systemic lupus erythematosus].

F Meiss1, M Fischer, J Hädecke, M Knorrn, W C Marsch.   

Abstract

Graves disease is a frequent cause (30-40%) of hyperthyroidism. In addition to the classic clinical triad (goiter, exophthalmos and tachycardia), symptoms relating to other organ systems may be found at presentation. Cutaneous manifestations play an important role and may initially be the only clue to the endocrine disorder. A 40-year-old woman with Graves disease presented with features of systemic lupus erythematosus. She had a malar rash, as well as marked hematological changes (thrombocytopenia and leukocytopenia) and antinuclear antibodies (1:640). She also had hyperthyroidism and Graves disease-specific thyroid autoantibodies (TSIg). Her symptoms improved after initiation of antithyroid therapy. Because of overlapping clinical and laboratory criteria, Graves disease can mimic systemic lupus erythematosus. The differentiation requires careful laboratory evaluation. Moreover, both autoimmune diseases may occur in the same patient.

Entities:  

Mesh:

Year:  2004        PMID: 15024472     DOI: 10.1007/s00105-004-0720-9

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  16 in total

Review 1.  Graves' disease.

Authors:  A P Weetman
Journal:  N Engl J Med       Date:  2000-10-26       Impact factor: 91.245

Review 2.  Graves' disease is a multi-system autoimmune disorder in which extra ocular muscle damage and connective tissue inflammation are variable features.

Authors:  Jack R Wall
Journal:  Thyroid       Date:  2002-01       Impact factor: 6.568

3.  Adolescent systemic lupus erythematosus and Graves' disease.

Authors:  Z Abraham; M Rozenbaum; E J Feuerman; A Kinarty; N Lahat
Journal:  Clin Exp Rheumatol       Date:  1994 Jan-Feb       Impact factor: 4.473

4.  [Changes in the blood picture in hyperthyroidism].

Authors:  K Hambsch; F Herrmann; H Fischer; D Langpeter; P Mäller; D Sorger
Journal:  Z Gesamte Inn Med       Date:  1989-05-15

5.  Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts.

Authors:  Jane Pritchard; Noah Horst; William Cruikshank; Terry J Smith
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

Review 6.  Pathogenesis of ophthalmopathy in autoimmune thyroid disease.

Authors:  A E Heufelder
Journal:  Rev Endocr Metab Disord       Date:  2000-01       Impact factor: 6.514

Review 7.  Autoimmune thyroid disease: propagation and progression.

Authors:  Anthony P Weetman
Journal:  Eur J Endocrinol       Date:  2003-01       Impact factor: 6.664

8.  Thyroid disorders in systemic lupus erythematosus.

Authors:  K L Goh; F Wang
Journal:  Ann Rheum Dis       Date:  1986-07       Impact factor: 19.103

9.  Presence of antideoxyribonucleic acid antibody in patients with hyperthyroidism of Graves' disease.

Authors:  M Katakura; T Yamada; T Aizawa; K Hiramatsu; Y Yukimura; M Ishihara; N Takasu; K Maruyama; M Kameko; M Kanai
Journal:  J Clin Endocrinol Metab       Date:  1987-03       Impact factor: 5.958

10.  Disorders of granulopoiesis in patients with untreated Graves' disease.

Authors:  A Ponassi; L Morra; G Caristo; G B Parodi; P Biassoni; C Sacchetti
Journal:  Acta Haematol       Date:  1983       Impact factor: 2.195

View more
  1 in total

Review 1.  CD4+ Cytotoxic T Cells Involved in the Development of EBV-Associated Diseases.

Authors:  Manuel Ruiz-Pablos
Journal:  Pathogens       Date:  2022-07-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.